more importantly at the 4 month point 5 out of 6 showed progression free survival ? is that how you read it ?
in other words
50% of patients(3/6) had 30% reduction of tumour size that sustained for 2 months at the end of 4 months
another 30% or 2/6 Patients had a stable disease at the end of 4 months
so almost 80%+ had progression free disease ?
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial, page-22
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.1¢ |
Change
-0.005(5.21%) |
Mkt cap ! $32.60M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.1¢ | $228.9K | 2.380M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34540 | 9.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| ATX (ASX) Chart |